Muscle force is typically proportional to muscle size, resulting in constant force normalized to muscle fiber cross-sectional area (specific force). Mice over-expressing insulin like growth factor-1 (IGF-1) exhibit a proportional gain in muscle force and size, but not the myostatin deficient mice. In an attempt to explore the role of the cytoplasmic volume supported by individual myonuclei (myonuclear domain size, MND) on functional capacity of skeletal muscle, we have investigated specific force in relation to MND and the content of the molecular motor protein, myosin, at the single muscle fiber level from myostatin knock-out (Mstn 
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INTRODUCTION
Skeletal muscle plasticity is well documented and muscle size is large in response to e.g., functional overload, exercise and hormonal influences. In general, muscle force is proportional to the cross-sectional area of the contractile material (specific force), but a gain in muscle size need not result in maintained specific force. Muscle cells are post-mitotic fixed multinuclear cells with hundreds of nuclei dispersed along the length of the cell. Each nucleus controls gene transcription in a finite volume of cytoplasm, the myonuclear domain (MND). The hypothesis that an increase in DNA content is a prerequisite for maintenance of metabolic/work demands and transport distances in hypertrophied is supported in some (1-4) but not all studies (5, 6) .
In this context, two important signaling molecules that regulate muscle growth are IGF-1 and myostatin (7-9), but they have strikingly different effects on specific force. IGF-1 is a protein with anabolic effects on muscle and muscle hypertrophy has been closely linked with an increased IGF-1 expression. A mouse model has been developed where IGF-1 is expressed in skeletal muscle via a tissue-restricted transgene (10) . These mice show a larger muscle mass than wild-type mice which is characterized by maintained specific force (11) (12) (13) and satellite cell activation has been proposed to be the source of new myonuclei in these fibers (4) .
Myostatin, a member of the TGF-β super family, is a negative regulator of skeletal muscle mass (14) . Inhibition of myostatin or its gene results larger in muscle mass than wild-type mice (14) (15) (16) . However, this hypertrophy is dissimilar from IGF-1 mediated hypertrophy in that the specific force has been reported to be less in myostatin null mice (9, 17) . However, contractile measurements have typically been measured at the whole muscle level and it cannot be excluded that changes in specific force are secondary to changes in muscle fiber orientation rather than changes in the contractile properties at the single muscle fiber level.
Both IGF-1 and myostatin signaling pathways have been considered for the pharmacological treatment of different muscle wasting conditions, and clinical trials have been initiated with the aim of improving muscle mass and function in patients with severe muscle wasting. Ultimately, the success of these trials will be evaluated with regard to muscle function and patients' quality of life, and not solely on the changes in muscle mass. Thus, there is accordingly a significant need for an improved mechanistic understanding of the effects of these interventions on skeletal muscle mass and function.
We hypothesize that the myonuclear organization differs between hypertrophic muscle (20) . All mice were euthanized after removal of muscle tissues.
Single fiber contractile measurements
The experimental procedure has been described in detail elsewhere (21) . Briefly, the skinned muscle fiber were used with an average segment length of 1.60 ± 0.20 mm (mean ± SD, range 1.00-2.00 mm) exposed to the solution between the connectors of the force transducer. The sarcomere length (SL) of the single-fiber segment was set to 2.65 ± 0.05 μm (range 2.60-2.70 μm) by adjusting the overall segment length. Fiber CSA was calculated from the width and depth, assuming an elliptical circumference. Specific tension (ST) was calculated as maximum tension (P o ) normalized to CSA, and was corrected for the 20% swelling that is known to occur during skinning (22) Relaxing and activating solutions were prepared as previously described (21) . Maximum active tension (P o ) was calculated as the difference between the total tension in the activating solution (pCa 4.5) and the resting tension measured in the same segment while in the relaxing solution. All contractile measurements were carried out at 15 °C. The contractile recordings were accepted in subsequent analyses only if P o did not change more than 10% from first to final activation, or if SL during isometric tension development did not change by more than 0.10 μm compared with SL when the fiber was relaxed (22) .
Stiffness
Once steady-state isometric force was reached, small-amplitude sinusoidal changes in length (ΔL:
± 0.2% of fiber length), were applied at 500 Hz at one end of the fiber (23) . The resultant force response (ΔF) was measured, and the mean of 20 consecutive readings of ΔL and ΔF was used to determine stiffness. The actual elastic modulus (E) was calculated as the difference between E in activating solutions and resting E measured in the same segment in the relaxing solution. E was determined as follows (24) A detailed description of procedures is given elsewhere (18) .
Enzyme Histochemistry
Frozen samples from the soleus muscles from all three groups were cut perpendicular to the longitudinal axis of the muscle fibers into 10µm cross-sections with a cryotome (2800 Frigo-cut E, Reichert-Jung GmbH, Heidelberg, Germany) at -20 0 C. The sections were stained for the demonstration of myofibrillar ATPase activity after alkaline (10.3) and acid (4.5) pre-incubations and classified into type I, IIA and IIB fibers. Succinate dehydrogenase (SDH) staining were performed as described elsewhere (25) .
Proximity ligation assay
A proximity ligation assay was performed to quantify myosin using the Duolink in situ PLA kit (Olink Bioscience, Uppsala) according to the manufacturer's instructions. Muscle's crosssections from control, Mstn -/-and mIgf1 +/+ mice were either fixed on the same glass slide or on different glass slides using 2 % paraformaldehyde. MF-20 (1: 5, DSHB, Iowa, USA) was used as primary antibody. Slides were examined with a confocal microscope (LSM510Meta; Zeiss, Jena, Germany) under a X40 objective and the analysis of the fluorescent signal was performed using
Imaris software (version 5.7.2). Assessment of pixel counts was done after applying a constant threshold and selectivity value. Three X40 fields were randomly chosen for analysis and averaged per condition examining three different samples separately. Whether the sections were on the same slide or not did not yield any different results.
Single fiber gel electrophoresis
A detailed description of procedures is given elsewhere (21) . In short, the MyHC composition of single fibers was determined by SDS-PAGE. The total acryl amide and bis concentrations were 4% (w/v) in the stacking gel and 6% in the running gel, and the gel matrix included 30% glycerol.
Polymerization was activated by adding TEMED to the stacking (0.1%) and separation gels (0.07%). Sample loads were kept small to improve the resolution of the MyHC bands and electrophoresis was performed at 120 V for 22-24 h with a Tris-glycine electrode buffer (pH 8.3) at 10°.
Statistical Analysis
A two-way ANOVA was used to compare fiber CSA, MND and force measurements across all three groups. Wherever a significant difference was found, Holm-Sidak post hoc test was used for comparisons between groups. Data normality was tested according to Kolmogorov-Smirnove test.
Linear regression analysis was done across individual fibers pooled according to MND size and CSA. All values are expressed as mean ± SEM (Standard Error of Mean). P < 0.05 was considered statistically significant.
RESULTS
Muscle weights
Higher EDL and soleus muscle weights were observed in both Mstn -/-and mIgf1 +/+ mice compared with age-and strain-matched controls ( MyHC isoforms is summarized in Table 3 . In short, both experimental groups showed a trend towards a fast phenotype, albeit not statistically significant when compared with controls.
Myonuclear phenotype and spatial organization
In muscle fibers expressing fast MyHC isoforms from both EDL and soleus muscles, myonuclei with an elliptical shape dominated and the longitudinal axes of the nuclei were typically aligned with the longitudinal axis of the fiber (Fig. 1) . In muscle fibers expressing the slow MyHC isoform, myonuclei with a rounded shape were predominant, but both shapes of myonuclei were frequently observed in the same fiber segments irrespective of MyHC isoform expression. Similar patterns of myonuclei shape and arrangement were observed in control and experimental groups, with the exception of EDL muscle fibers from the mIgf1 +/+ group where a deviation from the alignment of the elliptical myonuclei along the longitudinal axis was observed. Further, EDL muscle fibers from mIgf1 +/+ mice had significantly more internal nuclei than any other fiber population. Central nuclei constituted about 10% of all nuclei in EDL fibers and approximately 40% of the nuclei in muscle fibers expressing the type IIb MyHC isoform. Internal nuclei were, on the other hand, rare in soleus muscle fibers from all groups and in EDL muscle fibers from controls and Mstn -/-mice and constituted only 1-2% of all nuclei in these fibers.
The number of nuclei per fiber length and the size of individual MNDs were measured along the length of single muscle fiber segments using a novel algorithm (18) . Myonuclei close to the terminal parts of fiber segments were excluded from analysis since their MNDs may extend outside the fiber segment and give rise to erroneously small MNDs. Uniform MND sizes were observed along the length of individual muscle fibers in both controls and experimental groups (Fig. 2) . A significant increase (p<0.05) in myonuclear number was only observed in hypertrophic EDL muscle fibers from the mIgf1 +/+ group ( (Fig. 3) . This shows that mitochondrial content may not be the prime determinant of MND size at least in Mstn -/-mice fibers.
A linear relationship was observed between MND size and fiber CSA in controls and in the experimental groups (Fig. 4) . In EDL, a strong linear relationship was observed between both MND and CSA in Mstn -/-(r = 0.68; p < 0.001) and in mIgf1 +/+ mice (r = 0.64; p < 0.001; Fig. 4A ).
In soleus, on the other hand, a significant relationship was only found in type I fibers from 
Contractile properties
A total of 272 muscle fibers (EDL, n=131 and soleus n=141) fulfilled the criteria for acceptance and were included in the analyses of contractile properties in controls, Mstn -/-and mIgf1 +/+ mice.
In the EDL, absolute force (Fig. 5A) (Fig. 5C ). In the soleus, stiffness did not differ between experimental and control groups in accordance with specific force measurements. It is noted that average specific force and stiffness variables are lower, albeit not statistically significant, in Mstn -/-soleus fibers (Fig. 5 B, C) . Thus, the lower stiffness in parallel with the lower specific force in EDL fibers from Mstn -/-mice indicate a reduced number of functional cross-bridges underlying the reduced specific force in these mice, since fiber stiffness (Fig. 5C ) is primarily dependent on the number of attached cross-bridges (27) .
Myosin content
The content of the molecular motor protein myosin in the two experimental groups was measured in muscle cross-sections and related to the content in control muscles using a proximity ligation assay (Fig. 5D ). Muscle sections from controls and experimental groups were fixed and stained on the same glass. In the EDL, Mstn -/-mice myosin content per CSA was 23% lower (p<0.05) than in controls, while mIgf1 +/+ mice had a similar myosin content as in controls (Fig. 5D ). In the soleus, myosin contents per CSA were similar in all three groups in accordance with specific force and stiffness measurements.
DISCUSSION
Results from this study have confirmed and extended our understanding of the mechanisms underlying the altered contractile properties associated with different modes of hypertrophy and the major findings from this study are as follows: (i) a dramatic muscle fiber growth in response posit that there is a critical MND above which muscle fibers cannot adequately support contractile proteins for maintenance of force production, and that the cytoplasmic volume supported by individual myonuclei is a potential mechanism underlying altered functional capacity in hypertrophic muscle fibers.
Addition of myonuclei is a prerequisite for maintained specific force in hypertrophic fast-twitch EDL muscle fibers
In accordance with previous studies, larger MNDs were observed in muscle fibers expressing fast MyHC isoforms (28, 29) . The results from this study demonstrate that an additional enlargement In accordance with recent studies, the fiber hypertrophy in myostatin deficient muscles occurred without addition of myonuclei (8, 30, 31) . This is probably a consequence of the lack of satellite cell activation, supported by the small number of internal nuclei in Mstn -/-mice.
Mitochondrial depletion has been forwarded as a mechanism underlying the specific force in Mstn -/-mice (32). This is supported by a shift towards fast glycolytic IIb fibers and fewer mitochondria per unit volume in hypertrophic muscle from myostatin deficient mice together with a strong relationship between volume of mitochondria and MND size, particularly among fast fibers (33) . Although a shift towards fast IIb fibers with a low mitochondrial content was observed in the Mstn -/-mice, this is not the cause of the loss in specific force in the membrane permeabilized muscle fibers in this study. Use of the single fiber preparation eliminates the influence of ATP production by mitochondria on excitation-contraction coupling. The changes observed in the force-generation capacity of these muscle fibers reside in the final functional contractile unit in the muscle cell, i.e., the sarcomere. This does not, however, exclude the possibility that mitochondrial depletion may play an important role for in vivo physiological properties of skeletal muscle in myostatin deficient mice.
In contrast to observations in Mstn -/-mice, the muscle hypertrophy in myosin light chain mIgf1 +/+ mice was associated with a proportional increase in force, and resulted in maintained specific force. This confirms with previous observations in α-actin/igf1 (13) and MyLC/migf1 transgenic models (11, 12) . An increase in myonuclei number was observed in the mIgf1
, but the gain in muscle fiber size was proportionally larger than the increase in myonuclei number.
Thus, MNDs were approximately 10 % larger and resulted in a domain size around 31,700 µm 3 . It is suggested that this volume corresponds to a MND size close to the maximum synthetic capacity a myonucleus can support to maintain myofibriller protein content and number of functioning cross bridges intact.
A uniform distribution of myonuclei was observed in EDL and soleus muscles from controls, Mstn -/-and mIgf1 +/+ (Fig. 1) . This is in contrast to our recent observation of an agingrelated increase MND size variability in single muscle fibers from old humans (18) . The agingrelated loss in specific force and preferential myosin loss (34, 35) may accordingly be dependent on individual myonuclei exceeding their upper cytoplasmic volume to maintain an optimal concentration of contractile proteins.
Specific force is maintained with expanded myonuclear domains in the slow-twitch soleus
Soleus has a higher protein turnover rate than EDL with a protein half life of 7-8 days almost half that of EDL (36) . Mouse soleus is predominantly composed of fibers expressing the type I and IIa
MyHC isoform.
Despite a fiber type specific difference in hypertrophy in Mstn -/-and mIgf1 +/+ groups, both
IIa and I fibers maintained their myonuclei number and this resulted in a strong relationship between MND size and fiber size in both experimental groups. In spite of a significant higher MND size in type IIa fibers, the MND (23,000-26,000 µm 3 ) was still smaller than in control EDL and suggests sufficient transport distances and nuclear transcriptional potential to maintain specific force, stiffness and myosin quantity.
The constant myonuclear number in both experimental groups indicates a hypertrophic response independent of satellite cell activation in the soleus. This is supported by the few internal nuclei and conforms with previous observations in myostatin null mice demonstrating that satellite cells did not contribute to hypertrophy (37) or to an increase in protein/DNA ratio (38) .
The satellite cell independent hypertrophy of soleus muscle fibers in mIgf1 +/+ mice challenges established concepts, since high levels of the MyLC/igf-1promoter have been reported to be restricted to fast-twitch fibers (10, 39) . A maintained specific force in hypertrophic soleus muscle fibers is in accordance with previous observations in myostatin deficient (17) and IGF-1 transgenic mice (12) . That is, an gain in MND size to ~24,000um 3 does not compromise force generating capacity of hypertrophied fibers because MND has not reached maximum capacity. In contrast to the soleus, the upper limit of MND is exceeded in EDL fibers from the myostatin deficient mice, resulting in depressed strength. However, post-natal inhibition of myostatin where the hypertrophic response is less robust may enable maintenance of specific force. A recent study supports this concept, since it was observed that the specific force of the EDL muscle was maintained with myostatin inhibition that resulted in 16% hypertrophy, but not when hypertrophy was nearly 40% of the control values (45) . Other factors may contribute to optimal force production, for it may be that the limit of cytoplasmic expansion that can be accommodated without loss of specific force is dependent on transcriptional, translational and protein degradation rates as well as nuclear domain.
Conclusion
There is an increasing interest in both the myostatin and IGF-1 signaling pathways in the pharmacological treatment of many different muscle wasting conditions. The muscle hypertrophy in myostatin null and IGF-1 over expressing mice may be beneficial in terms of absolute muscle force secondary to fiber hypertrophy and hyperplasia. However, results from the present study show that these interventions have different and muscle specific effects related to myonuclear organization. The fast-twitch EDL has a higher MND than either fiber type in the soleus, and this appears to be optimally tuned for generating force. Therefore, hypertrophy must be accompanied by new myonuclear incorporation to maintain MND, and this is only achieved by increased IGF-1
and not by myostatin depletion. However, because the soleus fibers have a much lower MND to start with, there is a larger dynamic range for hypertrophy without the need for new myonuclei.
Thus, soleus fibers can undergo greater proportional hypertrophy and not suffer functional consequences. Because human muscle fibers span a similar varied range of MND with respect to age, gender, and fiber type (18, 19) the response differences in MND should be considered when developing human therapeutic strategies for boosting muscle mass. 
